What is NDC 70436-151?

70436-151 is the product NDC for Arformoterol Tartrate Inhalation, Arformoterol tartrate 15 ug/2mL solution, listed with the FDA by Slate Run Pharmaceuticals. It has 2 package NDCs, shown above in 10- and 11-digit form.

Slate Run Pharmaceuticals, NDC labeler code 70436. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Arformoterol Tartrate Inhalation?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Arformoterol Tartrate Inhalation NDC 70436-151

NDC codes

FDA NDC Directory

Product NDC (as listed)70436-151Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70436-0151Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70436-151-57	7043601515770436015157	30 POUCH in 1 CARTON (70436-151-57) / 1 VIAL in 1 POUCH (70436-151-19) / 2 mL in 1 VIALMarketed from Jun 22, 2021
70436-151-58	7043601515870436015158	15 POUCH in 1 CARTON (70436-151-58) / 4 VIAL in 1 POUCH (70436-151-20) / 2 mL in 1 VIALMarketed from Jun 22, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Arformoterol Tartrate Inhalation
Generic name (nonproprietary): arformoterol tartrate inhalation
Active ingredients: Arformoterol tartrate — 15 ug/2mL
Dosage form: Solution
Route: Respiratory (Inhalation)
Labeler: Slate Run PharmaceuticalsNDC labeler code 70436
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213762
Marketing start: Jun 22, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta2-Agonists (Mechanism)
Identifiers: Product ID 70436-151_3bd6ebed-0405-445a-8613-ae20b2e70703SPL ID 3bd6ebed-0405-445a-8613-ae20b2e70703SPL set ID 7d639762-091b-471e-9355-c2f4737676a2RxCUI 668956UNII 5P8VJ2I235
Pharmacologic class: beta2-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N470436015157 followed by a unit qualifier and the quantity

Package 70436-0151-57. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 24, 2023.

Indications (excerpt from the label)

Arformoterol tartrate inhalation solution is a long-acting beta 2 -adrenergic agonist (beta 2 -agonist) indicated for: • Long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. ( 1.1 ) Important limitations of use: • Arformoterol tartrate inhalation solution is not indicated to treat acute deteriorations of chronic obstructive pulmonary disease. ( 1.2 , 5.2 ) • Arformoterol tartrate inhalation solution is not indicated to treat asthma. ( 1.2 ) 1.1 Maintenance Treatment of COPD Arformoterol tartrate inhalation solution is indicated …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70436-151

What is NDC 70436-151?: 70436-151 is the product NDC for Arformoterol Tartrate Inhalation, Arformoterol tartrate 15 ug/2mL solution, listed with the FDA by Slate Run Pharmaceuticals. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Arformoterol Tartrate Inhalation.
What is the active ingredient?: Arformoterol tartrate.
Who is the labeler?: Slate Run Pharmaceuticals, NDC labeler code 70436. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Arformoterol Tartrate Inhalation?: 1 other product NDC are listed under this name. See all Arformoterol Tartrate Inhalation NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Arformoterol Tartrate Inhalation NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Arformoterol Tartrate Inhalation	Arformoterol tartrate 15 ug/2mL	SolutionRespiratory (Inhalation)	Devatis, Inc.	73043-052	73043-0052-6073043-0052-93